These data demonstrate that in patients with metabolic syndrome and type 2 diabetes, who can be characterized by the term “euglycaemic dysmetabolism”, insulin-dependent functional activity (irrespective of hyperinsulinaemia) could be diverse or even inverse in different organs. This evidence concerns the gene INS and metabolic syndrome.